Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Downgrades

Downgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Citigroup Downgrades Domino’s Pizza to Neutral, Lowers Price Target to $316

By Benzinga Newsdesk
February 24, 6:40 AM
Citigroup analyst Jon Tower downgrades Domino's Pizza (NYSE:DPZ) from Buy to Neutral and lowers the price target from $429 to $316.

DPZ

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Credit Suisse Downgrades CURO Group Holdings to Neutral, Lowers Price Target to $4

By Benzinga Newsdesk
February 24, 6:36 AM
Credit Suisse analyst Moshe Orenbuch downgrades CURO Group Holdings (NYSE:CURO) from Outperform to Neutral and lowers the price target from $7 to $4.

CURO

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target
  • Tech

Economic Uncertainty, Controlled Ad Spend, Lower Visibility Restrict AppLovin’s Upside, Analyst Says

By Anusuya Lahiri
February 23, 1:41 PM
UBS analyst John Hodulik downgraded AppLovin Corp (NASDAQ:APP) from Buy to Neutral and lowered the price target from $59 to $16. While…

APP

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Sidoti & Co. Downgrades Federal Agricultural to Neutral, Announces $139 Price Target

By Benzinga Newsdesk
February 23, 12:29 PM
Sidoti & Co. analyst Brendan McCarthy downgrades Federal Agricultural (NYSE:AGM) from Buy to Neutral and announces $139 price target.

AGM

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

BTIG Downgrades Wingstop to Neutral

By Benzinga Newsdesk
February 23, 8:10 AM
BTIG analyst Peter Saleh downgrades Wingstop (NASDAQ:WING) from Buy to Neutral.

WING

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Oppenheimer Downgrades Unity Software to Perform

By Benzinga Newsdesk
February 23, 8:08 AM
Oppenheimer analyst Martin Yang downgrades Unity Software (NYSE:U) from Outperform to Perform.

U

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Cowen & Co. Downgrades Graphite Bio to Market Perform

By Benzinga Newsdesk
February 23, 6:52 AM
Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.

GRPH

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Wolfe Research Downgrades AMETEK to Peer Perform

By Benzinga Newsdesk
February 23, 6:48 AM
Wolfe Research analyst Nigel Coe downgrades AMETEK (NYSE:AME) from Outperform to Peer Perform.

AME

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

JP Morgan Downgrades Alignment Healthcare to Neutral, Lowers Price Target to $12

By Benzinga Newsdesk
February 23, 6:46 AM
JP Morgan analyst Lisa Gill downgrades Alignment Healthcare (NASDAQ:ALHC) from Overweight to Neutral and lowers the price target from $22 to $12.

ALHC

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

JMP Securities Downgrades INDUS Realty Trust to Market Perform

By Benzinga Newsdesk
February 23, 5:55 AM
JMP Securities analyst Mitch Germain downgrades INDUS Realty Trust (NASDAQ:INDT) from Market Outperform to Market Perform.

INDT

Posts pagination

Previous 1 … 77 78 79 … 277 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service